The STUNS foundation has recruited Björn Arvidsson to fulfill the role of new operations manager for the foundation’s life science branch Uppsala BIO.
“During his 10 years at Roche, Björn has had several roles within diagnostics and pharmaceuticals, from product responsibility to marketing and communication, and policy development. This, together with the acquired experiences from various parts of the Swedish innovation system, makes Björn an excellent fit for mobilizing Uppsala’s innovation system in life science and healthcare at a time when industry boundaries are being blurred and disparate areas seem to be intertwined,” says Andreas Larsson, CEO of STUNS.
Björn’s most recent engagement has been at the Swiss pharmaceutical and diagnostics giant Roche. Björn has a background in chemistry studies at the Uppsala biomedical center (BMC) at Uppsala University and has pursued doctoral studies focusing on early diagnostics in the Department of Analytical Chemistry and has been a researcher at the Swedish Defense Research Institute FOI in Umeå.
Björn took up the position on September 1, and he replaced Erik Forsberg who took up the position Managing Director at EIT Health Scandinavia.
Photo: Jeanette Hägglund
